Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2

Blood

Volumn 118, Issue 2, 2011, Pages 416-424

  Konopatskaya, Olga ^a   Matthews, Sharon A ^b   Harper, Matthew T ^a   Gilio, Karen ^c   Cosemans, Judith M E M ^c   Williams, Christopher M ^a   Navarro, Maria N ^b   Carter, Deborah A ^a   Heemskerk, Johan W M ^c   Leitges, Michael ^d   Cantrell, Doreen ^b   Poole, Alastair W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GRANULE PROTEIN; INTEGRIN ALPHA2BBETA3; MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE D; PROTEIN KINASE D2; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOGENESIS;

EID: 79960504480     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-312199     Document Type: Article

References (42)

1. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9(2):154-69.
2. Konopatskaya O, Gilio K, Harper MT, et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest. 2009;119(2):399-407.
3. Buensuceso CS, Obergfell A, Soriani A, et al. Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. J Biol Chem. 2005;280(1):644-653. (Pubitemid 40165031)
4. Soriani A, Moran B, de Virgilio M, et al. A role for PKCtheta in outside-in alpha(IIb)beta3 signaling. J Thromb Haemost. 2006;4(3):648-655.
5. Chari R, Getz T, Nagy B Jr, et al. Protein kinase Cδ differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol. 2009;29(5):699-705.
6. Nagy B Jr., Bhavaraju K, Getz T, Bynagari YS, Kim S, Kunapuli SP. Impaired activation of platelets lacking protein kinase C-theta isoform. Blood. 2009;113(11):2557-2567.
7. Gilio K, Harper MT, Cosemans JM, et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem. 2010;285(30):23410-23419.
8. Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci. 2006;27(6):317-323. (Pubitemid 43850003)
9. Matthews SA, Navarro MN, Sinclair LV, Emslie EA, Feijoo-Carnero MC, Cantrell D. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. Biochem J. 2010;432(1):153-163.
10. Jacamo R, Sinnett-Smith J, Rey O, Waldron RT, Rozengurt E. Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation. J Biol Chem. 2008;283(19):12877-12887.
11. Sturany S, Van Lint J, Gilchrist A, Vandenheede JR, Adler G, Seufferlein T. Mechanism of activation of protein kinase D2 (PKD2) by the CCK(B)/gastrin receptor. J Biol Chem. 2002;277(33):29431-29436. (Pubitemid 41079227)
12. Ge X, Low B, Liang M, Fu J. Angiotensin II directly triggers endothelial exocytosis via protein kinase C-dependent protein kinase D2 activation. J Pharmacol Sci. 2007;105(2):168-176. (Pubitemid 350106806)
13. Stafford MJ, Watson SP, Pears CJPKD: a new protein kinase C-dependent pathway in platelets. Blood. 2003;101(4):1392-1399. (Pubitemid 36182511)
14. Watkins NA et al. HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood. 2009;113(19):e1-9.
15. Pula G, Schuh K, Nakayama K, Nakayama KI, Walter U, Poole A. WPKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood. 2006;108(13):4035-4044. (Pubitemid 44913272)
16. Kuijpers MJE, Schulte V, Bergmeier W, et al. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J. 2003;17(6):685-687.
17. Liu Q, Chen X, Macdonnell SM, et al. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res. 2009;105(2):194-200.
18. Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost. 2010;8(3):454-462.
19. Zugaza JL, Sinnett-Smith J, Van Lint J, Rozengurt E. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 1996;15(22):6220-6230. (Pubitemid 26397895)
20. Zugaza JL, Waldron RT, Sinnett-Smith J, Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J Biol Chem. 1997;272(38):23952-23960. (Pubitemid 27410978)
21. Hao Q,Wang L, Tang H. Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am J Physiol Cell Physiol. 2009;296(4):C821-C827.
22. Wong C, Jin ZG. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem. 2005;280(39):33262-33269. (Pubitemid 41397122)
23. Fielitz J, Kim MS, Shelton JM, et al. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci U S A. 2008;105(8):3059-3063. (Pubitemid 351723667)
24. Lavalle CR, Bravo-Altamirano K, Giridhar KV, et al. Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem Biol. 2010;10:5.
25. Sharlow ER, Giridhar KV, LaValle CR, et al. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. J Biol Chem. 2008;283(48):33516-33526.
26. Torres-Marquez E, Sinnett-Smith J, Guha S, et al. CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathway. Biochem Biophys Res Commun. 2010;391(1):63-68.
27. Monovich L, Vega RB, Meredith E, et al. A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase. FEBS Lett. 2010;584(3):631-637.
28. Liljedahl M, Maeda Y, Colanzi A,Ayala I, Van Lint J, Malhotra V. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell. 2001;104(3):409-420. (Pubitemid 32206461)
29. Sumara G, Formentini I, Collins S, et al. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell. 2009;136(2):235-248.
30. Woods AJ, White DP, Caswell PT, Norman JCPKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. EMBO J. 2004;23(13):2531-2543. (Pubitemid 38988225)
31. White DP, Caswell PT, Norman JC. Alphavbeta3 and alpha5beta1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration. J Cell Biol. 2007;177(3):515-525. (Pubitemid 46718279)
32. Medeiros RB, Dickey DM, Chung H, et al. Protein kinase D1 and the beta 1 integrin cytoplasmic domain control beta 1 integrin function via regulation of Rap1 activation. Immunity. 2005;23(2):213-226. (Pubitemid 41169290)
33. Stefanini L, Bergmeier W. CalDAG-GEFI and platelet activation. Platelets. 2010;21(4):239-243.
34. Avkiran M, Rowland AJ, Cuello F, Haworth RS. Protein kinase D in the cardiovascular system: emerging roles in health and disease. Circ Res. 2008;102(2):157-163. (Pubitemid 351651119)
35. Abedi H, Rozengurt E, Zachary I. Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells. FEBS Lett. 1998;427(2):209-212. (Pubitemid 28225059)
36. Qin L, Zeng H, Zhao DJ. Requirement of protein kinase D tyrosine phosphorylation for VEGFA165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J Biol Chem. 2006;281(43):32550-32558. (Pubitemid 46036810)
37. Tan M, Hao F, Xu X, Chisolm GM, Cui MZ. Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration. Arterioscler Thromb Vasc Biol. 2009;29(9):1376-1382.
38. Hao Q, Wang L, Zhao ZJ, Tang H. Identification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesis. J Biol Chem. 2009;284(2):799-806.
39. Konopatskaya O, Poole AW. Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci. 2010;31(1):8-14.
40. Xu H, Czerwinski P, Hortmann M, Sohn HY, Förstermann U, Li H. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res. 2008;78(2):349-355. (Pubitemid 351556090)
41. Takahashi K, Shimokado K, Yoshida M. SDF-1-induced adhesion of monocytes to vascular endothelium is modulated by azelnidipine via protein kinase C inhibition. Eur J Pharmacol. 2006;552(1-3):162-169. (Pubitemid 44648085)
42. Leszczynski D, Joenväärä, S., Foegh ML. Protein kinase C-alpha regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells. Life Sci. 1996;58(7):599-606.